MENEGUZZI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.148
EU - Europa 904
AS - Asia 354
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 2.412
Nazione #
US - Stati Uniti d'America 1.144
GB - Regno Unito 368
CN - Cina 334
IT - Italia 142
SE - Svezia 101
IE - Irlanda 74
FR - Francia 72
DE - Germania 54
FI - Finlandia 54
UA - Ucraina 15
BE - Belgio 13
VN - Vietnam 11
CA - Canada 4
KR - Corea 3
RU - Federazione Russa 3
AL - Albania 2
AU - Australia 2
ES - Italia 2
IL - Israele 2
TR - Turchia 2
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
NL - Olanda 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 2.412
Città #
Southend 331
Chandler 224
Jacksonville 177
Woodbridge 144
Verona 96
Dublin 73
Beijing 69
Ashburn 68
New York 68
Ann Arbor 55
Houston 54
Norwalk 53
Jinan 33
Nanjing 33
Lawrence 31
Princeton 31
Wilmington 30
Shenyang 29
Hebei 18
Lancaster 17
Changsha 16
Tianjin 14
Brussels 13
Ningbo 13
Zhengzhou 13
Helsinki 11
Nanchang 10
Taiyuan 10
Jiaxing 9
Dong Ket 7
Haikou 7
Lanzhou 7
Taizhou 7
Sindelfingen 6
Bologna 5
Fuzhou 5
Redwood City 5
Cento 4
Chicago 4
Clearwater 4
Fairfield 4
Guangzhou 4
Milan 4
Redmond 4
Seattle 4
Detroit 3
Dongguan 3
Hangzhou 3
Phoenix 3
Seoul 3
Boardman 2
Falls Church 2
Gazzo 2
Leawood 2
London 2
Provo 2
Riva 2
San Diego 2
Tirana 2
Toronto 2
Trento 2
Washington 2
Adliswil 1
Almaty 1
Amsterdam 1
Andover 1
Bassano Del Grappa 1
Boston 1
Bratislava 1
Böblingen 1
Cairo 1
Catania 1
Charlotte 1
Chateauguay 1
Chisinau 1
Cupertino 1
Dearborn 1
Esslingen am Neckar 1
Hanover 1
Jerusalem 1
Kemerovo 1
La Canada Flintridge 1
Los Angeles 1
Manassas 1
Mestre 1
Montréal 1
Nashville 1
Oakland 1
Perth 1
Radcliffe 1
Saint Louis 1
San Francisco 1
Santiago 1
Southwest Brevard Cnty 1
Stockton 1
Venice 1
Waterford 1
Worcester 1
Xiangfen 1
Yicheng 1
Totale 1.901
Nome #
Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia. 116
Overexpression of TNF-α in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria. 106
Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles 102
NCX4016 (NO-aspirin) inhibits thromboxane biosynthesis and tissue factor expression and activity in human monocytes. 97
NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. 97
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease 92
Endothelial dysfunction in mitochondrial diseases: biological and biochemical evidence of increased oxidative stress and peroxinitrite generation 90
Collagen I and III mRNA gene expression and cell growth potential of skin fibroblasts in patients with essential hypertension. 89
Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. 88
Inibitori della cicloossigenasi e cardiopatia ischemica 86
Elevated plasma levels of soluble TNF-alpha Receptor 1 (sTNFR1) in preeclampsia associated with fetal growth restriction 85
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. 84
Inhibition of TF expression on activated monocytes: potential role in the anti-thrombotic activity of NCX-4016 82
The PTGS-1 P17L polymorphism enhances urinary thromboxane production and is associated with stroke incidence in men. 82
Determinants of the variability of thromboxane inhibition by aspirin in patients with cardiovascular disease 78
Lycopene inhibits endothelial cells migration induced by vascular endothelial growth factor A increasing nitric oxide bioavailability 78
Reduced platelet count, but no major platelet function abnormalities, are associated with loss of function ATP-binding cassette-1 (ABCA1) gene mutations 77
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. 76
Increased Soluble TNF-Alpha Receptor 1 is Associated with Preeclampsia and Fetal Growth Restriction. 73
Co-administration of NO-Aspirin (NCX-4016) and Aspirin prevents platelet and monocyte activation and protects against damage induced by aspirin in humans. 72
null 70
Residual thromboxane biosynthesis is associated with platelet activation in high risk patients treated with low dose aspirin 69
Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs 67
XXIV National Congress of the Italian Society for Thrombosis and Hemostasis - SISET: Abano Terme (PD), Italy 9-12 November 2016 66
Inibitori della cicloossigenasi e cardiopatia ischemica 65
NO-Aspirin (NCX-4016) prevents platelet and monocyte activation inducing less gastric damage compared to aspirin 64
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 61
Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence 60
Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence? 52
Expression and functional characterization of the large-conductance calcium and voltage-activated potassium channel Kca 1.1 in megakaryocytes and platelets 44
Interference of C6O4 on platelet aggregation pathways: Cues on the new-generation of perfluoro-alkyl substance 44
Genetic grafting of membrane-acting peptides to the cytotoxin dianthin augments its ability to de-stabilize lipid bilayers and enhances its cytotoxic potential as the component of transferrin-toxin conjugates. 24
Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells 14
Totale 2.450
Categoria #
all - tutte 7.349
article - articoli 5.080
book - libri 0
conference - conferenze 1.554
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 715
Totale 14.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 1 2
2019/2020357 29 3 4 22 29 43 79 24 13 40 33 38
2020/2021354 59 28 18 33 102 22 2 22 25 6 18 19
2021/2022275 44 93 0 22 7 4 2 13 8 10 23 49
2022/2023573 40 67 54 79 60 128 7 54 64 2 13 5
2023/2024254 17 14 21 23 32 94 6 31 1 15 0 0
Totale 2.450